Three private equity firms are planning to sell stakes worth INR 30 billion to INR 40 billion in Mankind Pharma Limited (NSEI:MANKIND) through block deals on 12 December 2023, according to news reports. Chrys Capital, The Capital Group Companies, Inc. and Everbridge Partners are looking to sell 5% to 6% stake in the pharmaceutical major. Kotak Mahindra Capital is one of the advisors to the deal, and the private equity investors are offering a discount of upto 7% from the current price.

The floor price has been set at INR 1,785.65 a share.